New molecular imaging agent targets cornerstone of cancerous tumors
Monday, June 6, 2011 - 14:00
in Health & Medicine
A study introduced at SNM's 58th Annual Meeting may lead to the next wave of cancer imaging by helping to develop a molecular imaging agent that detects many malignant cancers' incessant development of blood vesselsa process called angiogenesis. A protein biomarker known as CD105 has been shown to indicate tumor angiogenesis in cancer patients.